Encompass Health Corp Stock Analysis
EHC Stock | USD 99.40 0.47 0.48% |
Encompass Health Corp is fairly valued with Real Value of 100.09 and Target Price of 81.89. The main objective of Encompass Health stock analysis is to determine its intrinsic value, which is an estimate of what Encompass Health Corp is worth, separate from its market price. There are two main types of Encompass Health's stock analysis: fundamental analysis and technical analysis.
The Encompass Health stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Encompass Health's ongoing operational relationships across important fundamental and technical indicators.
Encompass |
Encompass Stock Analysis Notes
About 98.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 1.37. Encompass Health Corp last dividend was issued on the 2nd of January 2025. The entity had 1257:1000 split on the 1st of July 2022. Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama. Encompass Health operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 34900 people. To learn more about Encompass Health Corp call Mark Tarr at 205 967 7116 or check out https://www.encompasshealth.com.Encompass Health Quarterly Total Revenue |
|
Encompass Health Corp Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Encompass Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Encompass Health Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Over 98.0% of the company shares are held by institutions such as insurance companies | |
On 15th of October 2024 Encompass Health paid $ 0.17 per share dividend to its current shareholders | |
Latest headline from news.google.com: Ontario Teachers Pension Plan Board Has 1.84 Million Stake in Encompass Health Co. - MarketBeat |
Encompass Health Corp Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Encompass Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
7th of February 2024 Upcoming Quarterly Report | View | |
25th of April 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
7th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Encompass Largest EPS Surprises
Earnings surprises can significantly impact Encompass Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2007-03-01 | 2006-12-31 | -0.09 | -0.08 | 0.01 | 11 | ||
2011-10-27 | 2011-09-30 | 0.19 | 0.17 | -0.02 | 10 | ||
1995-10-18 | 1995-09-30 | 0.14 | 0.16 | 0.02 | 14 |
Encompass Health Environmental, Social, and Governance (ESG) Scores
Encompass Health's ESG score is a quantitative measure that evaluates Encompass Health's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Encompass Health's operations that may have significant financial implications and affect Encompass Health's stock price as well as guide investors towards more socially responsible investments.
Encompass Health Thematic Classifications
In addition to having Encompass Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
HealthcareUSA Equities from Healthcare industry as classified by Fama & French |
Encompass Stock Institutional Investors
Shares | Hhg Plc | 2024-06-30 | 1.6 M | Citadel Advisors Llc | 2024-06-30 | 1.5 M | Bank Of New York Mellon Corp | 2024-06-30 | 1.5 M | Brown Advisory Holdings Inc | 2024-09-30 | 1.5 M | Td Global Investment Solutions – Td Epoch | 2024-06-30 | 1.5 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.4 M | Copeland Capital Management, Llc | 2024-09-30 | 1.3 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 1.1 M | Norges Bank | 2024-06-30 | 1.1 M | Vanguard Group Inc | 2024-09-30 | 10.3 M | Blackrock Inc | 2024-06-30 | 9 M |
Encompass Market Capitalization
The company currently falls under 'Mid-Cap' category with a total capitalization of 9.97 B.Encompass Profitablity
The company has Net Profit Margin of 0.08 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.15 %, which entails that for every 100 dollars of revenue, it generated $0.15 of operating income.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.08 | 0.05 | |
Return On Capital Employed | 0.13 | 0.11 | |
Return On Assets | 0.06 | 0.03 | |
Return On Equity | 0.21 | 0.22 |
Management Efficiency
Encompass Health Corp has Return on Asset of 0.0838 % which means that on every $100 spent on assets, it made $0.0838 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2292 %, implying that it generated $0.2292 on every 100 dollars invested. Encompass Health's management efficiency ratios could be used to measure how well Encompass Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.22, whereas Return On Tangible Assets are forecasted to decline to 0.05. At present, Encompass Health's Deferred Long Term Asset Charges is projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.46, whereas Total Assets are forecasted to decline to about 3.8 B.Last Reported | Projected for Next Year | ||
Book Value Per Share | 23.09 | 24.24 | |
Tangible Book Value Per Share | 7.41 | 7.78 | |
Enterprise Value Over EBITDA | 9.45 | 9.92 | |
Price Book Value Ratio | 4.03 | 4.23 | |
Enterprise Value Multiple | 9.45 | 9.92 | |
Price Fair Value | 4.03 | 4.23 | |
Enterprise Value | 9.2 B | 9.7 B |
Examining the leadership quality of Encompass Health Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Dividend Yield 0.0069 | Operating Margin 0.1548 | Profit Margin 0.081 | Forward Dividend Yield 0.0069 | Beta 0.78 |
Technical Drivers
As of the 22nd of November, Encompass Health shows the Downside Deviation of 1.08, mean deviation of 0.8827, and Semi Deviation of 0.8585. Encompass Health Corp technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Encompass Health Corp Price Movement Analysis
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Encompass Health middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Encompass Health Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Encompass Health Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Encompass Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Encompass Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Encompass Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Encompass Health Outstanding Bonds
Encompass Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Encompass Health Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Encompass bonds can be classified according to their maturity, which is the date when Encompass Health Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
ENELIM 68 15 SEP 37 Corp BondUS29268BAC54 | View | |
ENELIM 6 07 OCT 39 Corp BondUS29268BAF85 | View | |
ENCOMPASS HEALTH P Corp BondUS29261AAE01 | View | |
Encompass Health 45 Corp BondUS29261AAA88 | View | |
Encompass Health 475 Corp BondUS29261AAB61 | View | |
US29267HAA77 Corp BondUS29267HAA77 | View |
Encompass Health Predictive Daily Indicators
Encompass Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Encompass Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Encompass Health Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 13th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 1st of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 28th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 17th of October 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 14th of August 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 6th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Encompass Health Forecast Models
Encompass Health's time-series forecasting models are one of many Encompass Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Encompass Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Encompass Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Encompass Health prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Encompass shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Encompass Health. By using and applying Encompass Stock analysis, traders can create a robust methodology for identifying Encompass entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.13 | 0.13 | |
Operating Profit Margin | 0.15 | 0.14 | |
Net Profit Margin | 0.07 | 0.06 | |
Gross Profit Margin | 0.19 | 0.18 |
Current Encompass Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Encompass analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Encompass analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
81.89 | Strong Buy | 13 | Odds |
Most Encompass analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Encompass stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Encompass Health Corp, talking to its executives and customers, or listening to Encompass conference calls.
Encompass Stock Analysis Indicators
Encompass Health Corp stock analysis indicators help investors evaluate how Encompass Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Encompass Health shares will generate the highest return on investment. By understating and applying Encompass Health stock analysis, traders can identify Encompass Health position entry and exit signals to maximize returns.
Begin Period Cash Flow | 53.4 M | |
Long Term Debt | 2.7 B | |
Common Stock Shares Outstanding | 101.3 M | |
Total Stockholder Equity | 1.6 B | |
Tax Provision | 126.9 M | |
Quarterly Earnings Growth Y O Y | 0.26 | |
Property Plant And Equipment Net | 3.5 B | |
Cash And Short Term Investments | 69.1 M | |
Cash | 69.1 M | |
Accounts Payable | 170 M | |
Net Debt | 2.9 B | |
50 Day M A | 96.8388 | |
Total Current Liabilities | 656.4 M | |
Other Operating Expenses | 4.1 B | |
Non Current Assets Total | 5.3 B | |
Forward Price Earnings | 20.7039 | |
Non Currrent Assets Other | 82.1 M | |
Stock Based Compensation | 50.6 M |
Complementary Tools for Encompass Stock analysis
When running Encompass Health's price analysis, check to measure Encompass Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Encompass Health is operating at the current time. Most of Encompass Health's value examination focuses on studying past and present price action to predict the probability of Encompass Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Encompass Health's price. Additionally, you may evaluate how the addition of Encompass Health to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |